Ignite Creation Date:
2025-12-24 @ 10:58 PM
Ignite Modification Date:
2025-12-25 @ 8:26 PM
Study NCT ID:
NCT00319969
Status:
COMPLETED
Last Update Posted:
2009-09-30
First Post:
2006-04-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.
Sponsor:
Celgene Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-04
Start Date Type:
None
Primary Completion Date:
2008-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-01
Completion Date Type:
ACTUAL
First Submit Date:
2006-04-27
First Submit QC Date:
None
Study First Post Date:
2006-04-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2009-09-30
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2009-09-28
Last Update Post Date:
2009-09-30
Last Update Post Date Type:
ESTIMATED